Applied nanotechnology has emerged as a transformative force in the pharmaceutical field, offering innovative solutions to longstanding challenges. At the nanoscale, materials exhibit unique properties that can be harnessed to enhance drug delivery, diagnostics, and therapeutic efficacy. Nanoparticles, for instance, enable targeted drug delivery, optimizing treatment outcomes while minimizing side effects. This precision is especially crucial in cancer therapy, where nanotechnology allows for the selective delivery of drugs to tumor cells. Additionally, nanoscale drug formulations enhance solubility and bioavailability, overcoming obstacles faced by traditional formulations.
Diagnostic tools incorporating nanotechnology provide sensitive and early detection of diseases, revolutionizing patient monitoring. The interplay of nanotechnology and pharmaceuticals holds great promise for personalized medicine, ushering in a new era of tailored treatments that maximize efficacy and minimize adverse effects. As research in applied nanotechnology continues to advance, its impact on the pharmaceutical field is poised to redefine the landscape of healthcare, offering novel solutions for improved patient outcomes.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico